Toward the harmonization of immune monitoring in clinical trials: quo vadis?
Cancer Immunol Immunother
.
2008 Mar;57(3):285-8.
doi: 10.1007/s00262-007-0379-z.
Epub 2007 Aug 25.
Authors
C M Britten
1
,
S Janetzki
,
S H van der Burg
,
C Gouttefangeas
,
A Hoos
Affiliation
1
Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands. cebritten@web.de
PMID:
17721782
PMCID:
PMC2150641
DOI:
10.1007/s00262-007-0379-z
No abstract available
Publication types
Comment
MeSH terms
Clinical Trials as Topic
Humans
Immunotherapy*
Monitoring, Immunologic / standards*
Neoplasms / therapy*
Predictive Value of Tests